JP2024542728A5 - - Google Patents

Info

Publication number
JP2024542728A5
JP2024542728A5 JP2024532709A JP2024532709A JP2024542728A5 JP 2024542728 A5 JP2024542728 A5 JP 2024542728A5 JP 2024532709 A JP2024532709 A JP 2024532709A JP 2024532709 A JP2024532709 A JP 2024532709A JP 2024542728 A5 JP2024542728 A5 JP 2024542728A5
Authority
JP
Japan
Application number
JP2024532709A
Other languages
Japanese (ja)
Other versions
JP2024542728A (ja
JPWO2023102490A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/080766 external-priority patent/WO2023102490A1/en
Publication of JP2024542728A publication Critical patent/JP2024542728A/ja
Publication of JPWO2023102490A5 publication Critical patent/JPWO2023102490A5/ja
Publication of JP2024542728A5 publication Critical patent/JP2024542728A5/ja
Pending legal-status Critical Current

Links

JP2024532709A 2021-12-01 2022-12-01 てんかんの治療のための組成物及び方法 Pending JP2024542728A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163284932P 2021-12-01 2021-12-01
US63/284,932 2021-12-01
PCT/US2022/080766 WO2023102490A1 (en) 2021-12-01 2022-12-01 Compositions and methods for treatment of epilepsies

Publications (3)

Publication Number Publication Date
JP2024542728A JP2024542728A (ja) 2024-11-15
JPWO2023102490A5 JPWO2023102490A5 (https=) 2025-12-08
JP2024542728A5 true JP2024542728A5 (https=) 2025-12-08

Family

ID=86613118

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024532709A Pending JP2024542728A (ja) 2021-12-01 2022-12-01 てんかんの治療のための組成物及び方法

Country Status (8)

Country Link
EP (1) EP4441229A1 (https=)
JP (1) JP2024542728A (https=)
KR (1) KR20240159663A (https=)
CN (1) CN118974255A (https=)
AU (1) AU2022402159A1 (https=)
CA (1) CA3241122A1 (https=)
MX (1) MX2024006709A (https=)
WO (1) WO2023102490A1 (https=)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2019218987B2 (en) * 2018-02-12 2025-04-24 Ionis Pharmaceuticals, Inc. Modified compounds and uses thereof
US20220056455A1 (en) * 2018-12-20 2022-02-24 Praxis Precision Medicines, Inc. Compositions and methods for the treatment of kcnt1 related disorders
PE20220168A1 (es) * 2019-03-15 2022-01-28 Ionis Pharmaceuticals Inc Compuestos y metodos para reducir la expresion de kcnt1

Similar Documents

Publication Publication Date Title
BR102023014872A2 (https=)
BR102023012440A2 (https=)
BR102023010976A2 (https=)
BR102023009641A2 (https=)
BR102023008688A2 (https=)
BR102023007252A2 (https=)
BR102023005164A2 (https=)
BR102023001877A2 (https=)
JP2024542728A5 (https=)
BR202022009269U2 (https=)
BR202022005961U2 (https=)
BR202022001779U2 (https=)
BR202022000931U2 (https=)
CN307047242S (https=)
CN307048024S (https=)
CN307046495S (https=)
CN307045751S (https=)
CN307045609S (https=)
CN307045383S (https=)
CN307045160S (https=)
BY13135U (https=)
CN307044927S (https=)
CN307044511S (https=)
CN307044441S (https=)
CN307044290S (https=)